You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-FLT3 (FLT3) Antibodies

Full name:
anti-Fms-Related tyrosine Kinase 3 Antibodies (FLT3)
On are 336 Fms-Related tyrosine Kinase 3 (FLT3) Antibodies from 33 different suppliers available. Additionally we are shipping FLT3 Kits (33) and FLT3 Proteins (25) and many more products for this protein. A total of 404 FLT3 products are currently listed.
B230315G04, CD135, FLK-2, FLK2, Flt-3, FLT3, Ly72, STK1, wmfl
list all antibodies Gene Name GeneID UniProt
FLT3 14255 Q00342
FLT3 2322 P36888
FLT3 140635  

Show all species

Show all synonyms

Most Popular Reactivities for anti-FLT3 (FLT3) Antibodies

Select your species and application

anti-Mouse (Murine) FLT3 Antibodies:

anti-Human FLT3 Antibodies:

anti-Rat (Rattus) FLT3 Antibodies:

All available anti-FLT3 Antibodies

Go to our pre-filtered search.

Top referenced anti-FLT3 Antibodies

  1. Human Polyclonal FLT3 Primary Antibody for EIA, IHC (p) - ABIN359869 : Seidlits, Reza, Briand, Sereno: Voluntary spatial attention has different effects on voluntary and reflexive saccades. in TheScientificWorldJournal 2003 (PubMed)
    Show all 5 references for ABIN359869

  2. Human Polyclonal FLT3 Primary Antibody for EIA, IHC (p) - ABIN359868 : Minami, Yamamoto, Kiyoi, Ueda, Saito, Naoe: Different antiapoptotic pathways between wild-type and mutated FLT3: insights into therapeutic targets in leukemia. in Blood 2003 (PubMed)
    Show all 5 references for ABIN359868

  3. Human Polyclonal FLT3 Primary Antibody for FACS, IHC (p) - ABIN391981 : Zwaan, Meshinchi, Radich, Veerman, Huismans, Munske, Podleschny, Hählen, Pieters, Zimmermann, Reinhardt, Harbott, Creutzig, Kaspers, Griesinger: FLT3 internal tandem duplication in 234 children with acute myeloid leukemia: prognostic significance and relation to cellular drug resistance. in Blood 2003 (PubMed)
    Show all 4 references for ABIN391981

  4. Human Polyclonal FLT3 Primary Antibody for IHC (p), WB - ABIN391982 : Sitnicka, Buza-Vidas, Larsson, Nygren, Liuba, Jacobsen et al.: Human CD34+ hematopoietic stem cells capable of multilineage engrafting NOD/SCID mice express flt3: distinct flt3 and c-kit expression and response patterns on mouse and candidate human hematopoietic ... in Blood 2003 (PubMed)
    Show all 4 references for ABIN391982

  5. Human Polyclonal FLT3 Primary Antibody for IF, WB - ABIN401556 : Sekine, Kataoka, Fukuyama, Adachi, Davydova, Yamamoto, Kobayashi, Fujihashi, Suzuki, Curiel, Shizukuishi, McGhee, Fujihashi: A novel adenovirus expressing Flt3 ligand enhances mucosal immunity by inducing mature nasopharyngeal-associated lymphoreticular tissue dendritic cell migration. in Journal of immunology (Baltimore, Md. : 1950) 2008 (PubMed)
    Show all 3 references for ABIN401556

  6. Human Polyclonal FLT3 Primary Antibody for EIA, IF - ABIN1449983 : Takahashi: Downstream molecular pathways of FLT3 in the pathogenesis of acute myeloid leukemia: biology and therapeutic implications. in Journal of hematology & oncology 2011 (PubMed)
    Show all 3 references for ABIN1449983

  7. Human Polyclonal FLT3 Primary Antibody for ELISA, WB - ABIN1532338 : Rosnet, Schiff, Pébusque, Marchetto, Tonnelle, Toiron, Birg, Birnbaum: Human FLT3/FLK2 gene: cDNA cloning and expression in hematopoietic cells. in Blood 1993 (PubMed)
    Show all 2 references for ABIN1532338

  8. Human Polyclonal FLT3 Primary Antibody for ELISA, WB - ABIN1532044 : Rosnet, Matteï, Marchetto, Birnbaum: Isolation and chromosomal localization of a novel FMS-like tyrosine kinase gene. in Genomics 1991 (PubMed)
    Show all 2 references for ABIN1532044

  9. Human Polyclonal FLT3 Primary Antibody for ELISA, WB - ABIN1531319 : Greenman, Stephens, Smith, Dalgliesh, Hunter, Bignell, Davies, Teague, Butler, Stevens, Edkins, OMeara, Vastrik, Schmidt, Avis, Barthorpe, Bhamra, Buck, Choudhury, Clements, Cole, Dicks, Forbes, Gray et al.: Patterns of somatic mutation in human cancer genomes. ... in Nature 2007 (PubMed)
    Show all 2 references for ABIN1531319

More Antibodies against FLT3 Interaction Partners

Mouse (Murine) Fms-Related tyrosine Kinase 3 (FLT3) interaction partners

  1. murine Fms-like tyrosine kinase 3 (Flt3) ligand (show FLT3LG Antibodies) was used to generate conventional dendritic cells (FL-cDCs) and plasmacytoid DCs (FL-pDCs) and further evaluated their immunological responses to bacillus Calmette-Guerin (BCG (show SLC11A1 Antibodies)) infection in vitro.

  2. increased number of osteoclasts in Flt3L (show FLT3LG Antibodies)(-/-) mice may be a consequence of insufficient expression of interferon regulatory factor 8 (show IRF8 Antibodies)

  3. FLT3-tandem duplication mutation directly affects dendritic cell development, indirectly modulating T cell homeostasis and supporting T reg (show KCNH2 Antibodies) cell expansion.

  4. MYB (show MYB Antibodies) and C/EBPalpha (show CEBPA Antibodies) activities are inter-dependent in controlling Flt3 expression to influence lineage commitment of multipotential progenitors.

  5. functional synergy between Flt3 and IL-4R signaling is critical for Stat (show STAT1 Antibodies)-mediated regulation of sterile gamma1 germ-line transcripts and CSR (show SCARA3 Antibodies) to IgG1

  6. STAT5 (show STAT5A Antibodies) activation by FLT3-ITD protects cells treated with the PI3K/Akt (show AKT1 Antibodies) pathway inhibitors from apoptosis by maintaining Mcl-1 (show MCL1 Antibodies) expression through the mTORC1/4EBP1 (show EIF4EBP1 Antibodies)/eIF4E (show EIF4E Antibodies) pathway.

  7. LAMTOR2 (show LAMTOR2 Antibodies) has a role in regulating dendritic cell homeostasis through FLT3-dependent mTOR (show FRAP1 Antibodies) signalling

  8. The Ras-PI3Kgamma (show PIK3CG Antibodies)-Akt (show AKT1 Antibodies)-mTOR (show FRAP1 Antibodies) signaling axis acts downstream of FLT3L (show FLT3LG Antibodies) signaling and is required for development of lung CD103 (show ITGAE Antibodies)(+)and CD11b (show ITGAM Antibodies)(+) dendritic cells. This signaling network regulating tissue-specific DC development is mediated by FLT3.

  9. These results reveal a leukemic pathway involving FAK (show PTK2 Antibodies)/Tiam1 (show TIAM1 Antibodies)/Rac1/PAK1 (show PAK1 Antibodies) and demonstrate an essential role for these signaling molecules in regulating the nuclear translocation of Stat5 (show STAT5A Antibodies) in leukemogenesis.

  10. Accumulation of FLT3(+) CD11c (show ITGAX Antibodies) (+) dendritic cells in psoriatic lesions and the anti-psoriatic effect of a selective FLT3 inhibitor

Human Fms-Related tyrosine Kinase 3 (FLT3) interaction partners

  1. Gelatin-coated Gold Nanoparticles as Carriers of FLT3 Inhibitors for Acute Myeloid Leukemia (show BCL11A Antibodies) Treatment.

  2. introduce the combined use of CD25 (show IL2RA Antibodies) and properly strati fi ed CD135 values as alternatives to testing for the FLT3-ITD mutation

  3. This study investigated the expression level of miR-1 (show FSD1 Antibodies), miR (show MLXIP Antibodies)-486, and let-7a in 45 CN-AML (show RUNX1 Antibodies) patients well characterized for FLT3 and/or NPM1 (show NPM1 Antibodies) mutations using real-time quantitative RT-PCR and evaluated the association between candidate miRs expression and clinical features

  4. Cabozantinib is selectively cytotoxic to leukemia cells with FLT3-ITD, causing cell-cycle arrest and apoptosis.

  5. The prevalence of FLT3 heterozygous mutations is more that homozygous mutations in AML (show RUNX1 Antibodies) patients.

  6. FLT3-ITD mutations were found in 10 patients.

  7. results identify CDC25C (show CDC25C Antibodies) as a downstream target of the mutated tyrosine kinase (show TXK Antibodies) FLT3-ITD affecting cell-cycle regulation in a model of AML (show RUNX1 Antibodies)

  8. FLT3 mutation is not frequent in Acute Myeloid Leukemia (show BCL11A Antibodies) in Pakistan.

  9. Data show that fyn proto-oncogene (show FYN Antibodies) protein (FYN (show FYN Antibodies)) expression is deregulated in acute myeloid leukemia (show BCL11A Antibodies) and that higher expression of FYN (show FYN Antibodies), in combination with FLT3 protein-ITD mutation, resulted in enrichment of the STAT5 (show STAT5A Antibodies) transcription factor signaling.

  10. Normal FLT3 and negative expression of CD34 (show CD34 Antibodies) and cMPL (show MPL Antibodies) may predict a longer overall survival in aute myeloid leukemia (show BCL11A Antibodies).

FLT3 Antigen Profile

Antigen Summary

This gene encodes a class III receptor tyrosine kinase that regulates hematopoiesis. The receptor consists of an extracellular domain composed of five immunoglobulin-like domains, one transmembrane region, and a cytoplasmic kinase domain split into two parts by a kinase-insert domain. The receptor is activated by binding of the fms-related tyrosine kinase 3 ligand to the extracellular domain, which induces homodimer formation in the plasma membrane leading to autophosphorylation of the receptor. The activated receptor kinase subsequently phosphorylates and activates multiple cytoplasmic effector molecules in pathways involved in apoptosis, proliferation, and differentiation of hematopoietic cells in bone marrow. Mutations that result in the constitutive activation of this receptor result in acute myeloid leukemia and acute lymphoblastic leukemia.

Alternative names and synonyms associated with FLT3

  • fms-related tyrosine kinase 3 (FLT3) antibody
  • FMS-like tyrosine kinase 3 (Flt3) antibody
  • fms-related tyrosine kinase 3 (Flt3) antibody
  • B230315G04 antibody
  • CD135 antibody
  • FLK-2 antibody
  • FLK2 antibody
  • Flt-3 antibody
  • FLT3 antibody
  • Ly72 antibody
  • STK1 antibody
  • wmfl antibody

Protein level used designations for FLT3

fms-related tyrosine kinase 3 , FL cytokine receptor-like , FL cytokine receptor , fetal liver kinase 2 , receptor-type tyrosine-protein kinase FLT3 , tyrosine-protein kinase FLT3 , tyrosine-protein kinase receptor flk-2 , CD135 antigen , STK-1 , fms-like tyrosine kinase 3 , growth factor receptor tyrosine kinase type III , stem cell tyrosine kinase 1 , FMS-like tyrosine kinase 3

452508 Pan troglodytes
100061780 Equus caballus
100413316 Callithrix jacchus
14255 Mus musculus
2322 Homo sapiens
140635 Rattus norvegicus
486025 Canis lupus familiaris
512700 Bos taurus
100858422 Gallus gallus
100515445 Sus scrofa
100732047 Cavia porcellus
Selected quality suppliers for anti-FLT3 (FLT3) Antibodies
Did you look for something else?